---
title: "LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-Driven Antibody Optimisation Programs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268563449.md"
description: "LabGenius Therapeutics announced a second collaboration with Sanofi. This collaboration combines LabGenius' AI/ML-driven antibody design capabilities with Sanofi's expertise in the development of therapeutic NANOBODY molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA platform to optimise NANOBODY molecules for multiple new targets in the area of inflammation."
datetime: "2025-12-04T09:10:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268563449.md)
  - [en](https://longbridge.com/en/news/268563449.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268563449.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/268563449.md) | [繁體中文](https://longbridge.com/zh-HK/news/268563449.md)


# LabGenius Therapeutics Announces New Collaboration with Sanofi for Multiple AI/ML-Driven Antibody Optimisation Programs

LabGenius Therapeutics announced a second collaboration with Sanofi. This collaboration combines LabGenius' AI/ML-driven antibody design capabilities with Sanofi's expertise in the development of therapeutic NANOBODY molecules to co-optimise proteins for therapeutically valuable properties. Following the success of their first collaboration, LabGenius will apply the EVA platform to optimise NANOBODY molecules for multiple new targets in the area of inflammation.

### Related Stocks

- [Sanofi (SNYNF.US)](https://longbridge.com/en/quote/SNYNF.US.md)

## Related News & Research

- [Sanofi’s Sarclisa Subcutaneous Formulation Via On-Body Injector Recommended For EU Approval](https://longbridge.com/en/news/280786871.md)
- [Sanofi Secures EU Conditional Marketing Approval for Graft-vs-Host Disease Medicine](https://longbridge.com/en/news/281129645.md)
- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/en/news/281311983.md)
- [SharonAI Secures Major Long-Term AI Cloud Services Deal](https://longbridge.com/en/news/281363534.md)
- [Realbotix to Deliver 19 AI Humanoid Robots as It Scales Production](https://longbridge.com/en/news/281387250.md)